Pharmacokinetic bioequivalence, safety and acceptability of Ornibel®, a new polymer composition contraceptive vaginal ring (eto
Non-interventional retrospective study to evaluate menstrual bleeding pro les, tolerability and quality of life of women using t
Pharmacokinetic bioequivalence, safety and acceptability of Ornibel®, a new polymer composition contraceptive vaginal ring (eto
![PDF) Pharmacokinetic bioequivalence, safety and acceptability of Ornibel ® , a new polymer composition contraceptive vaginal ring (etonogestrel/ethinylestradiol 11.00/3.474 mg) compared with Nuvaring ® (etonogestrel/ethinylestradiol 11.7/2.7 mg) PDF) Pharmacokinetic bioequivalence, safety and acceptability of Ornibel ® , a new polymer composition contraceptive vaginal ring (etonogestrel/ethinylestradiol 11.00/3.474 mg) compared with Nuvaring ® (etonogestrel/ethinylestradiol 11.7/2.7 mg)](https://i1.rgstatic.net/publication/322536735_Pharmacokinetic_bioequivalence_safety_and_acceptability_of_Ornibel_R_a_new_polymer_composition_contraceptive_vaginal_ring_etonogestrelethinylestradiol_11003474_mg_compared_with_Nuvaring_R_etonogestrel/links/5a6da88fa6fdcc317b184c87/largepreview.png)
PDF) Pharmacokinetic bioequivalence, safety and acceptability of Ornibel ® , a new polymer composition contraceptive vaginal ring (etonogestrel/ethinylestradiol 11.00/3.474 mg) compared with Nuvaring ® (etonogestrel/ethinylestradiol 11.7/2.7 mg)
![Pharmaceutics | Free Full-Text | The Vaginal Microbiota, Bacterial Biofilms and Polymeric Drug-Releasing Vaginal Rings Pharmaceutics | Free Full-Text | The Vaginal Microbiota, Bacterial Biofilms and Polymeric Drug-Releasing Vaginal Rings](https://www.mdpi.com/pharmaceutics/pharmaceutics-13-00751/article_deploy/html/images/pharmaceutics-13-00751-g001.png)